vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and SS&C Technologies Holdings Inc (SSNC). Click either name above to swap in a different company.
SS&C Technologies Holdings Inc is the larger business by last-quarter revenue ($1.6B vs $1.1B, roughly 1.5× PERRIGO Co plc). SS&C Technologies Holdings Inc runs the higher net margin — 13.7% vs -127.8%, a 141.5% gap on every dollar of revenue. On growth, SS&C Technologies Holdings Inc posted the faster year-over-year revenue change (8.8% vs -2.5%). Over the past eight quarters, SS&C Technologies Holdings Inc's revenue compounded faster (6.5% CAGR vs 1.3%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
SS&C Technologies Holdings, Inc. is an American multinational holding company headquartered in Windsor, Connecticut, that sells software and software as a service to the financial services industry. The company has offices in the Americas, Europe, Asia, Africa and Australia.
PRGO vs SSNC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.6B |
| Net Profit | $-1.4B | $226.1M |
| Gross Margin | 32.6% | 48.7% |
| Operating Margin | -116.0% | 24.2% |
| Net Margin | -127.8% | 13.7% |
| Revenue YoY | -2.5% | 8.8% |
| Net Profit YoY | -3093.9% | 6.2% |
| EPS (diluted) | $-10.23 | $0.91 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.6B | ||
| Q4 25 | $1.1B | $1.7B | ||
| Q3 25 | $1.0B | $1.6B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $1.0B | $1.5B | ||
| Q4 24 | $1.1B | $1.5B | ||
| Q3 24 | $1.1B | $1.5B | ||
| Q2 24 | $1.1B | $1.5B |
| Q1 26 | — | $226.1M | ||
| Q4 25 | $-1.4B | $193.1M | ||
| Q3 25 | $7.5M | $210.0M | ||
| Q2 25 | $-8.4M | $180.8M | ||
| Q1 25 | $-6.4M | $213.0M | ||
| Q4 24 | $-44.4M | $248.2M | ||
| Q3 24 | $-21.0M | $164.4M | ||
| Q2 24 | $-108.4M | $190.3M |
| Q1 26 | — | 48.7% | ||
| Q4 25 | 32.6% | 47.8% | ||
| Q3 25 | 36.1% | 47.7% | ||
| Q2 25 | 34.4% | 48.0% | ||
| Q1 25 | 37.6% | 49.3% | ||
| Q4 24 | 33.9% | 49.3% | ||
| Q3 24 | 37.2% | 48.0% | ||
| Q2 24 | 37.0% | 48.1% |
| Q1 26 | — | 24.2% | ||
| Q4 25 | -116.0% | 22.3% | ||
| Q3 25 | 7.0% | 23.3% | ||
| Q2 25 | 4.3% | 22.4% | ||
| Q1 25 | 4.5% | 23.6% | ||
| Q4 24 | 10.0% | 23.4% | ||
| Q3 24 | 7.4% | 22.2% | ||
| Q2 24 | -2.5% | 22.6% |
| Q1 26 | — | 13.7% | ||
| Q4 25 | -127.8% | 11.7% | ||
| Q3 25 | 0.7% | 13.4% | ||
| Q2 25 | -0.8% | 11.8% | ||
| Q1 25 | -0.6% | 14.1% | ||
| Q4 24 | -3.9% | 16.2% | ||
| Q3 24 | -1.9% | 11.2% | ||
| Q2 24 | -10.2% | 13.1% |
| Q1 26 | — | $0.91 | ||
| Q4 25 | $-10.23 | $0.76 | ||
| Q3 25 | $0.05 | $0.83 | ||
| Q2 25 | $-0.06 | $0.72 | ||
| Q1 25 | $-0.05 | $0.84 | ||
| Q4 24 | $-0.32 | $0.98 | ||
| Q3 24 | $-0.15 | $0.65 | ||
| Q2 24 | $-0.79 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $420.9M |
| Total DebtLower is stronger | — | $7.4B |
| Stockholders' EquityBook value | $2.9B | $6.9B |
| Total Assets | $8.5B | $20.3B |
| Debt / EquityLower = less leverage | — | 1.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $420.9M | ||
| Q4 25 | — | $462.1M | ||
| Q3 25 | $432.1M | $388.3M | ||
| Q2 25 | $454.2M | $480.3M | ||
| Q1 25 | $409.9M | $515.0M | ||
| Q4 24 | $558.8M | $567.1M | ||
| Q3 24 | $1.5B | $694.7M | ||
| Q2 24 | $542.8M | $462.7M |
| Q1 26 | — | $7.4B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $6.9B | ||
| Q4 25 | $2.9B | $6.9B | ||
| Q3 25 | $4.4B | $6.9B | ||
| Q2 25 | $4.5B | $6.9B | ||
| Q1 25 | $4.4B | $6.8B | ||
| Q4 24 | $4.3B | $6.5B | ||
| Q3 24 | $4.6B | $6.8B | ||
| Q2 24 | $4.5B | $6.4B |
| Q1 26 | — | $20.3B | ||
| Q4 25 | $8.5B | $20.7B | ||
| Q3 25 | $10.1B | $19.5B | ||
| Q2 25 | $10.1B | $19.0B | ||
| Q1 25 | $9.8B | $20.4B | ||
| Q4 24 | $9.6B | $19.0B | ||
| Q3 24 | $11.2B | $18.4B | ||
| Q2 24 | $10.4B | $16.9B |
| Q1 26 | — | 1.08× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | $299.7M |
| Free Cash FlowOCF − Capex | $148.6M | — |
| FCF MarginFCF / Revenue | 13.4% | — |
| Capex IntensityCapex / Revenue | 2.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.33× |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $299.7M | ||
| Q4 25 | $175.4M | $643.5M | ||
| Q3 25 | $51.7M | $456.2M | ||
| Q2 25 | $75.9M | $372.9M | ||
| Q1 25 | $-64.5M | $272.2M | ||
| Q4 24 | $312.6M | $486.6M | ||
| Q3 24 | $42.2M | $336.6M | ||
| Q2 24 | $9.5M | $384.9M |
| Q1 26 | — | — | ||
| Q4 25 | $148.6M | $633.0M | ||
| Q3 25 | $29.8M | $421.5M | ||
| Q2 25 | $56.7M | $350.0M | ||
| Q1 25 | $-90.0M | $259.5M | ||
| Q4 24 | $274.9M | $466.9M | ||
| Q3 24 | $15.1M | $310.7M | ||
| Q2 24 | $-18.9M | $374.9M |
| Q1 26 | — | — | ||
| Q4 25 | 13.4% | 38.3% | ||
| Q3 25 | 2.9% | 26.9% | ||
| Q2 25 | 5.4% | 22.8% | ||
| Q1 25 | -8.6% | 17.1% | ||
| Q4 24 | 24.2% | 30.5% | ||
| Q3 24 | 1.4% | 21.2% | ||
| Q2 24 | -1.8% | 25.8% |
| Q1 26 | — | 0.0% | ||
| Q4 25 | 2.4% | 0.6% | ||
| Q3 25 | 2.1% | 2.2% | ||
| Q2 25 | 1.8% | 1.5% | ||
| Q1 25 | 2.4% | 0.8% | ||
| Q4 24 | 3.3% | 1.3% | ||
| Q3 24 | 2.5% | 1.8% | ||
| Q2 24 | 2.7% | 0.7% |
| Q1 26 | — | 1.33× | ||
| Q4 25 | — | 3.33× | ||
| Q3 25 | 6.89× | 2.17× | ||
| Q2 25 | — | 2.06× | ||
| Q1 25 | — | 1.28× | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | — | 2.05× | ||
| Q2 24 | — | 2.02× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
SSNC
| Technology-enabled services | $1.4B | 85% |
| License, maintenance and related | $239.8M | 15% |
